Exact Mass: 615.1503

Exact Mass Matches: 615.1503

Found 24 metabolites which its exact mass value is equals to given mass value 615.1503, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cep-1347

methyl 10,23-bis[(ethylsulfanyl)methyl]-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-16-carboxylate

C33H33N3O5S2 (615.1862)

CXCR3 Antagonist 6c

4-[2-(3-chlorobenzamido)-4-{[2-(2,4-dichlorophenyl)ethyl]carbamoyl}phenyl]-N-ethyl-1,4-diazepane-1-carboxamide

C30H32Cl3N5O3 (615.1571)

Idasanutlin

4-[[3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carbonyl]amino]-3-methoxybenzoic acid

C31H29Cl2F2N3O4 (615.1503)

C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent > C162996 - MDM2 Inhibitor Idasanutlin (RG7388) is a potent and selective MDM2 antagonist, inhibiting p53-MDM2 binding, with an IC50 of 6 nM.

4-Chloro-N-{[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl}-N-(4-methoxyphenyl)benzohydrazide

C33H27Cl2N3O5 (615.1328)

Methyl 2,11-bis[(ethylsulfanyl)methyl]-15-hydroxy-8-methyl-5,6,7,8-tetrahydro-13H-5,8-epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4-jkl]cyclopenta[e]-as-indacene-7-carboperoxoate

C33H33N3O5S2 (615.1862)

N-[3-(4-{[1-(5-chloro-2,4-dimethoxyanilino)-1-oxopropan-2-yl]sulfanyl}anilino)-3-oxo-1-phenylprop-1-en-2-yl]benzamide

C33H30ClN3O5S (615.1595)

1,N-bis(2,4-dinitrophenyl)-L-histidyl-L-glutamine

C23H21N9O12 (615.131)

N-[(5S,6S,9R)-8-[1,3-benzodioxol-5-yl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2,2,2-trifluoroethanesulfonamide

C27H32F3N3O8S (615.1862)

N-[(5S,6R,9R)-8-[1,3-benzodioxol-5-yl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2,2,2-trifluoroethanesulfonamide

C27H32F3N3O8S (615.1862)

N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-chlorobenzenesulfonamide

C30H34ClN3O7S (615.1806)

N-[(5R,6R,9S)-8-[1,3-benzodioxol-5-yl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2,2,2-trifluoroethanesulfonamide

C27H32F3N3O8S (615.1862)

N-[(5R,6S,9S)-8-[1,3-benzodioxol-5-yl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2,2,2-trifluoroethanesulfonamide

C27H32F3N3O8S (615.1862)

N-[(5S,6R,9S)-8-[1,3-benzodioxol-5-yl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2,2,2-trifluoroethanesulfonamide

C27H32F3N3O8S (615.1862)

N-[(5R,6S,9R)-8-[1,3-benzodioxol-5-yl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2,2,2-trifluoroethanesulfonamide

C27H32F3N3O8S (615.1862)

3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-octadecanoylpyrrolidin-2-one

C28H43Br2NO4 (615.1559)

(7s,8s,12r,13s)-22-chloro-1,3,8,28-tetrahydroxy-7,12,21-trimethoxy-6-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-2,4(9),10,17(29),18(27),20,22,24-octaene-5,26-dione

(7s,8s,12r,13s)-22-chloro-1,3,8,28-tetrahydroxy-7,12,21-trimethoxy-6-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-2,4(9),10,17(29),18(27),20,22,24-octaene-5,26-dione

C29H26ClNO12 (615.1143)

12-[4-(acetyloxy)-3-methoxyphenyl]-18-hydroxy-8,16,17-trimethoxy-3-oxo-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17-octaen-7-yl acetate

C33H29NO11 (615.1741)

(3s)-3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-octadecanoylpyrrolidin-2-one

C28H43Br2NO4 (615.1559)